Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis

Fumihiko Hayakawa1, Martin L Privalsky

  • 1Section of Microbiology, Division of Biological Sciences, University of California at Davis, Davis, CA 95616, USA.

Cancer Cell
|April 20, 2004
PubMed

Insights

Arsenic trioxide (As(2)O(3)) triggers apoptosis in acute promyelocytic leukemia cells by phosphorylating the promyelocytic leukemia (PML) protein via MAP kinase pathways. This phosphorylation enhances PML

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • The promyelocytic leukemia (PML) protein acts as a tumor suppressor.
  • Aberrant PML-RARα fusions drive acute promyelocytic leukemia (APL).
  • Arsenic trioxide (As(2)O(3)) induces apoptosis in APL cells via an unclear mechanism.

Purpose of the Study:

  • To elucidate the mechanism by which As(2)O(3) induces apoptosis in APL cells.
  • To investigate the role of PML protein phosphorylation in As(2)O(3)-mediated apoptosis.

Main Methods:

  • Investigated As(2)O(3) effects on PML protein phosphorylation.
  • Utilized mitogen-activated protein (MAP) kinase pathway inhibitors.
  • Introduced phosphorylation and sumoylation-defective PML mutations.

Main Results:

  • As(2)O(3) treatment induces PML phosphorylation through MAP kinase pathways.
  • PML phosphorylation correlates with increased sumoylation and apoptosis.
  • MAP kinase inhibitors or defective PML mutations reduce As(2)O(3)-induced apoptosis.

Conclusions:

  • MAP kinase-mediated phosphorylation potentiates PML's antiproliferative activity.
  • PML phosphorylation is crucial for As(2)O(3)'s proapoptotic effects in APL.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...